二尖瓣瓣膜成形术对二尖瓣反流和左室收缩功能不全患者死亡率的影响

王亭忠 - 世界核心医学期刊文摘: 心脏病学分册, 2005 - cqvip.com
… regression analysis, including MVA as a time-dependent covariate and propensity scoring to
… Reduced risk was associated with angiotensin-converting enzyme inhibitors(HR 0.65, 95%…

血管紧张素转换酶抑制剂降低高血压患者心房纤颤的发生

宁宁 - 世界核心医学期刊文摘: 心脏病学分册, 2005 - cqvip.com
… on a propensity scoreAngiotensin-converting enzyme inhibitio n was associated with a
reduced incidence of AF for patients with hypertension ina usual care setting. These results need …

心脏保护性药物治疗与外周动脉疾病患者生存率改善相关

孙凯 - 世界核心医学期刊文摘: 心脏病学分册, 2006 - cqvip.com
… After adjustment for risk factors and propensity scores, statins(hazard ratio [HR] 0.46, 95%
confidence interval [CI] 0.36 to 0.58), beta-blockers(HR 0.68, 95% CI 0.58 to 0.80), aspirins(…

[HTML][HTML] 基于倾向性评分匹配法评估钠离子浓度对心力衰竭患者预后的影响

韩苏, 王传合, 佟菲, 杨丽娜, 崔文佳, 孙志军 - 中国医科大学学报, 2019 - html.rhhz.net
Propensity score matching at baseline and Cox regression analysis were performed, and …
紧张素受体拮抗剂(angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker, ACEI/…

真实世界研究的方法与实践

黄卓山, 罗艳婷, 刘金来 - 循证医学, 2014 - jebm.cn
… RWS requires giving propensity scores to decrease covariant malconformation among groups…
种血管紧张素转换酶抑制剂(angiotensinconverting enzyme inhibitors,ACEI) 对心力衰竭患 者…

Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the C …

S Kannan, KM Pantalone, S Matsuda… - Journal of …, 2016 - Wiley Online Library
… the study include the fact that the analysis was adjusted for many baseline variables (accurately
captured by the EHR) that have substantial effects on mortality, and propensity scoring

血管紧张素受体阻滞剂使用对COVID-19 高血压患者病毒载量, 抗体水平和转录特征的影响

B Feng, D Zhang, Q Wang, F Yu, Q Zou, G Xie… - Journal of Zhejiang …, 2021 - Springer
propensity score weighting method (Mehta et al., 2020). In another population-based case-control
study … Association of angiotensin-converting enzyme inhibitor or angiotensin receptor …

[HTML][HTML] 心脏移植术后急性肾损伤风险因素: 单中心报告

袁莉, 刘峻江, 杨兆华, 杨守国, 张红强, 王帆顺… - 复旦学报(医学 …, 2023 - jms.fudan.edu.cn
… 肾素-血管紧张素系统(renin-angiotensin system,RAS)抑制剂的使用者被定义为在手术前至少
1个月定期使用血管紧张素转换酶抑制剂(angiotensin converting enzyme inhibitor,ACEI)或血管…

[HTML][HTML] 真实世界中2 型糖尿病患者二甲双胍联用西格列汀的心血管安全性

刘佐相, 陈晓薇, 赵厚宇, 詹思延… - Journal of Peking …, 2024 - ncbi.nlm.nih.gov
… to propensity score model, … 剂(angiotensin converting enzyme inhibitor,ACEI)、血管紧张
素受体阻滞剂(angiotensin receptor blockers,ARB)、钙通道阻滞剂(calcium channel blockers,…

Changes in characteristics and management of A sian and A nglo‐C elts with type 2 diabetes over a 15‐year period in an urban A ustralian community: The F …

EDD Tan, WA Davis, TME Davis - Journal of Diabetes, 2016 - Wiley Online Library
… The use of antihypertensive therapies, especially angiotensin-converting enzyme inhibitors
(ACEIs) and angiotensin receptor blockers (ARBs), increased in both groups between …